Kenneth C. Frazier

2012

In 2012, Kenneth C. Frazier earned a total compensation of $15.5M as Chairman, President and Chief Executive Officer at Merck & Co., a 16% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$4,316,762
Non-Equity Incentive Plan$2,500,000
Option Awards$3,799,998
Salary$1,500,000
Stock Awards$3,284,997
Other$57,850
Total$15,459,607

Frazier received $4.3M of change in pension value and nonqualified deferred compensation earnings, accounting for 28% of the total pay in 2012.

Frazier also received $2.5M in non-equity incentive plan, $3.8M in option awards, $1.5M in salary, $3.3M in stock awards and $57.9K in other compensation.

Rankings

In 2012, Kenneth C. Frazier's compensation ranked 172nd out of 11,487 executives tracked by ExecPay. In other words, Frazier earned more than 98.5% of executives.

ClassificationRankingPercentile
All
172
out of 11,487
99th
Division
Manufacturing
65
out of 4,253
99th
Major group
Chemicals And Allied Products
13
out of 1,203
99th
Industry group
Drugs
8
out of 925
99th
Industry
Pharmaceutical Preparations
7
out of 700
99th
Source: SEC filing on April 13, 2015.

Frazier's colleagues

We found five more compensation records of executives who worked with Kenneth C. Frazier at Merck & Co. in 2012.

2012

Adam Schechter

Merck & Co.

Executive Vice President and President, Global Human Health

2012

Peter Kim

Merck & Co.

Executive Vice President and President, Merck Research Laboratories

2012

Peter Kellogg

Merck & Co.

Chief Financial Officer

2012

Richard Bowles

Merck & Co.

Executive Vice President and Chief Ethics & Compliance Officer

2012

Bruce Kuhlik

Merck & Co.

General Counsel

News

You may also like